Coronavirus (COVID-19)


Information and updates to help clinical and laboratory staff manage the impact of COVID-19

Text version of image
O- 8 days, A- 13 days, B- 9 days, AB- 10 days, O+ 9 days, A+ 10 days, B+ 9 days, AB+ 12 days 

Refer to the red cell shortage plan if stocks fall to less than 2 days 

Text version of image
O- 1.9 days, A- 1.3 days, B- 1.1days, AB- 1.7 days, O+ 1.2 days, A+ 1.4 days, B+ 1.6 days, AB+ 3.2 days 

Refer to the platelet shortage plan if stocks fall to 0.5 days or less

Participation in the clinical trials for convalescent plasma research

RECOVERY: This trial has stopped

More information

Read our 15 January communication

REMAP-CAP: This trial is paused and is entering into the data analysis phase


Read our 8 January communication
 

Blood supply updates

22 February 2021

  • Intelligence to support demand forecasting 
  • Stock management
  • Maintaining supply of blood components

Read 22 February update 

20 January 2021

  • This communication is to inform you about continuing drive to maximise the collection of high antibody titre CCP
  • Please continue to hold on to any unused CCP

Read 20 January update

Archive

Read our archived updates

 

Do you or your colleagues want to donate?

Please book an appointment by

Please be aware of the changes to testing and referring for:

Updates relating to: 

  • TAS - clinical and operational
  • Stem cells - NICE rapid guidance on haemopoietic stem cell transplantation 

Survey of blood component requirements in COVID-19 patients 

The aim of the survey is to establish levels of blood component use by swab positive COVID-19 patients admitted to hospital.